Elevation Oncology Stock (NASDAQ: ELEV) stock price, news, charts, stock research, profile.
Open | $0.62 |
Close | $0.60 |
Volume / Avg. | 449.94K / 1.33M |
Day Range | $0.60 - $0.62 |
52 Wk Range | 0.36 - 5.83 |
Market Cap | $35.29M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 22 |
Short Interest | 11.74% |
Days to Cover | 9.74 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Elevation Oncology (NASDAQ:ELEV) through any online brokerage.
Other companies in Elevation Oncology’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX), Gain Therapeutics (NASDAQ:GANX) and Curis (NASDAQ:CRIS).
Elevation Oncology has a consensus price target of $7.50.
The stock price for Elevation Oncology (NASDAQ: ELEV) is $0.597 last updated September 19, 2024 at 7:44 PM EDT.
There are no upcoming dividends for Elevation Oncology.
Elevation Oncology’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Elevation Oncology.
Elevation Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.